HQL

abrdn Life Sciences Investors
HQL

Overview Fund Activity

45 hedge funds and large institutions have $54.3M invested in abrdn Life Sciences Investors in 2014 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 11 reducing their positions, and 10 closing their positions.

Holders
45
Holders Change
-4
Holders Change %
-8.16%
% of All Funds
1.2%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
18
Reduced
11
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
CS
1
Credit Suisse
Switzerland
$2.45M
2
LPL Financial
2
LPL Financial
California
$2.57M
3
OC
3
Oppenheimer & Co
New York
$1.13M
4
NPC
4
National Planning Corporation
California
$732K
5
Invesco
5
Invesco
Georgia
$313K

Top Sellers

1
AAM
1
Advisors Asset Management
Colorado
$0
2
YCM
2
Yakira Capital Management
Connecticut
$0
3
VKH
3
Virtu KCG Holdings
New York
$0
4
Morgan Stanley
4
Morgan Stanley
New York
$13.6M
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
RFS
51
Rockefeller Financial Services
New York
– -$18K -825 Closed
FTUS
52
Flow Traders U.S.
New York
– -$1K -54 Closed
1 2
3